Connection

Dirk Jochmans to Cell Line

Back to Details
This is a "connection" page, showing publications Dirk Jochmans has written about Cell Line.
Dirk Jochmans
Connection Strength
0.162
Cell Line
  1. A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents. Antiviral Res. 2021 08; 192:105122.
    View in: PubMed
    Score: 0.074
  2. Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase. Antiviral Res. 2021 09; 193:105142.
    View in: PubMed
    Score: 0.019
  3. Betulonic Acid Derivatives Interfering with Human Coronavirus 229E Replication via the nsp15 Endoribonuclease. J Med Chem. 2021 05 13; 64(9):5632-5644.
    View in: PubMed
    Score: 0.018
  4. ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model. Biochem Biophys Res Commun. 2021 05 28; 555:134-139.
    View in: PubMed
    Score: 0.018
  5. Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones. ACS Infect Dis. 2018 04 13; 4(4):605-619.
    View in: PubMed
    Score: 0.015
  6. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014 Aug; 58(8):4875-84.
    View in: PubMed
    Score: 0.011
  7. Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother. 2008 Apr; 52(4):1302-17.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.